Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
Study to look at the effectiveness, tolerability and safety of two doses of Study Medication
 in Early Parkinson's Disease (PD) Patients who have not been treated with Levodopa.
Inclusion Criteria:

 Men and women with Parkinson's disease (PD) whose diagnosis is confirmed by at least two of
 the cardinal signs (resting tremor, bradykinesia, rigidity) being present, without other
 known or suspected cause of parkinsonism.

 Subjects must be age 35 years or older.

 Subjects not taking or requiring anti-parkinsonian medications, except for
 anticholinergics.

 Exclusion Criteria:

 Subjects with unstable systemic medical problems or clinically significant malignancy, with
 particular attention to clinically significant or unstable vascular disease